Prevention of Catheter-Related Bloodstream Infections

Advances in Surgery

Volumn 42, Issue C, 2008, Pages 229-248

  Rodriguez Paz, Jose M ^a   Pronovost, Peter ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; HUMAN; INDWELLING CATHETER; REVIEW; RISK FACTOR;

BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CROSS INFECTION; HUMANS; RISK FACTORS;

EID: 49849083965     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2008.03.012     Document Type: Review

References (118)

1. Forssmann W. Die Sondierung des Rechten Herzens. Klinische Wochenschrift 78 (1929) 489-492 [in German]
2. Merrer J., De Jonghe B., Golliot F., et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286 6 (2001) 700-707
3. McGee D.C., and Gould M.K. Preventing complications of central venous catheterization. N Engl J Med 348 12 (2003) 1123-1133
4. Raad I. Intravascular-catheter-related infections. Lancet 351 9106 (1998) 893-898
5. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 5 (2000) 391-402
6. Burke J.P. Infection control-a problem for patient safety. N Engl J Med 348 7 (2003) 651-656
7. Fraenkel D.J., Rickard C., and Lipman J. Can we achieve consensus on central venous catheter-related infections?. Anaesth Intensive Care 28 5 (2000) 475-490
8. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 8 (2004) 470-485
9. Rello J., Ochagavia A., Sabanes E., et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 1027-1030
10. Dimick J.B., Pelz R.K., Consunji R., et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136 2 (2001) 229-234
11. Smith R.L., Meixler S.M., and Simberkoff M.S. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100 1 (1991) 164-167
12. Harbarth S., Sax H., and Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 54 4 (2003) 258-266 [quiz 321]
13. Maki D.G., Kluger D.M., and Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81 9 (2006) 1159-1171
14. Blot S.I., Depuydt P., Annemans L., et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41 11 (2005) 1591-1598
15. Digiovine B., Chenoweth C., Watts C., et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 3 (1999) 976-981
16. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271 20 (1994) 1598-1601
17. Saint S., Veenstra D.L., and Lipsky B.A. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?. Infect Control Hosp Epidemiol 21 6 (2000) 375-380
18. Renaud B., Brun-Buisson C., and Icu-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163 7 (2001) 1584-1590
19. Blot S., De Bacquer D., Hoste E., et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 26 4 (2005) 352-356
20. Blot S., Vandewoude K., Hoste E., et al. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol 24 12 (2003) 912-915
21. Raymond D.P., Pelletier S.J., Crabtree T.D., et al. Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg 233 4 (2001) 549-555
22. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep 51 RR-10 (2002) 1-29
23. Garrouste-Orgeas M., Timsit J.F., Tafflet M., et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42 8 (2006) 1118-1126
24. Warren D.K., Quadir W.W., Hollenbeak C.S., et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 34 8 (2006) 2084-2089
25. Pittet D., Hulliger S., and Auckenthaler R. Intravascular device-related infections in critically ill patients. J Chemother 7 Suppl 3 (1995) 55-66
26. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 24 3 (2001) 180-205
27. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7 10 (2007) 645-657
28. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control 29 6 (2001) 404-421
29. Lorente L., Villegas J., Martin M.M., et al. Catheter-related infection in critically ill patients. Intensive Care Med 30 8 (2004) 1681-1684
30. Safdar N., and Maki D.G. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 30 1 (2004) 62-67
31. Pelletier S.J., Crabtree T.D., Gleason T.G., et al. Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes. J Am Coll Surg 190 6 (2000) 671-680 [discussion: 680-1]
32. Safdar N., Kluger D.M., and Maki D.G. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 81 6 (2002) 466-479
33. Gastmeier P., and Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 64 4 (2006) 326-335
34. Dimick J.B., Swoboda S., Talamini M.A., et al. Risk of colonization of central venous catheters: catheters for total parenteral nutrition vs other catheters. Am J Crit Care 12 4 (2003) 328-335
35. Chen H.S., Wang F.D., Lin M., et al. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect 39 3 (2006) 231-236
36. Moro M.L., Vigano E.F., and Cozzi Lepri A. Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group. Infect Control Hosp Epidemiol 15 4 Pt 1 (1994) 253-264
37. Richet H., Hubert B., Nitemberg G., et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 28 11 (1990) 2520-2525
38. Raad I., Umphrey J., Khan A., et al. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 23 1 (1993) 17-26
39. Mermel L.A., and Maki D.G. Infectious complications of Swan-Ganz pulmonary artery catheters. Pathogenesis, epidemiology, prevention, and management. Am J Respir Crit Care Med 149 4 Pt 1 (1994) 1020-1036
40. Linares J., Sitges-Serra A., Garau J., et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 21 3 (1985) 357-360
41. Sitges-Serra A., and Girvent M. Catheter-related bloodstream infections. World J Surg 23 6 (1999) 589-595
42. Stillman R.M., Soliman F., Garcia L., et al. Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg 112 12 (1977) 1497-1499
43. Sitges-Serra A. Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer 7 6 (1999) 391-395
44. Pearson M.L. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 17 7 (1996) 438-473
45. Pearson M.L. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24 4 (1996) 262-277
46. Rubinson L., Wu A.W., Haponik E.E., et al. Why is it that internists do not follow guidelines for preventing intravascular catheter infections?. Infect Control Hosp Epidemiol 26 6 (2005) 525-533
47. Rubinson L., and Diette G.B. Best practices for insertion of central venous catheters in intensive-care units to prevent catheter-related bloodstream infections. J Lab Clin Med 143 1 (2004) 5-13
48. Safdar N., and Maki D.G. Lost in translation. Infect Control Hosp Epidemiol 27 1 (2006) 3-7
49. Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation?. N Engl J Med 349 9 (2003) 868-874
50. McGlynn E.A., Asch S.M., Adams J., et al. The quality of health care delivered to adults in the United States. N Engl J Med 348 26 (2003) 2635-2645
51. Goldmann D. System failure versus personal accountability-the case for clean hands. N Engl J Med 355 2 (2006) 121-123
52. Boyce J.M., Larson E.L., and Weinstein R.A. Alcohol-based hand gels and hand hygiene in hospitals. Lancet 360 9344 (2002) 1509-1510 [author reply 1511]
53. Boyce J.M., Pittet D., Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America, and Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 23 Suppl 12 (2002) S3-S40
54. Albert R.K., and Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med 304 24 (1981) 1465-1466
55. Lankford M.G., Zembower T.R., Trick W.E., et al. Influence of role models and hospital design on hand hygiene of healthcare workers. Emerg Infect Dis 9 2 (2003) 217-223
56. Jenner E.A., Fletcher B.C., Watson P., et al. Discrepancy between self-reported and observed hand hygiene behaviour in healthcare professionals. J Hosp Infect 63 4 (2006) 418-422
57. Coopersmith C.M., Zack J.E., Ward M.R., et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch Surg 139 2 (2004) 131-136
58. Raad I.I., Hohn D.C., Gilbreath B.J., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15 4 Pt 1 (1994) 231-238
59. Mermel L.A., McCormick R.D., Springman S.R., et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 91 3B (1991) 197S-205S
60. Hu K.K., Lipsky B.A., Veenstra D.L., et al. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 32 3 (2004) 142-146
61. Hu K.K., Veenstra D.L., Lipsky B.A., et al. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 39 10 (2004) 1441-1445
62. Goetz A.M., Wagener M.M., Miller J.M., et al. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19 11 (1998) 842-845
63. Ruesch S., Walder B., and Tramer M.R. Complications of central venous catheters: internal jugular versus subclavian access-a systematic review. Crit Care Med 30 2 (2002) 454-460
64. Nagashima G., Kikuchi T., Tsuyuzaki H., et al. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization?. J Infect Chemother 12 6 (2006) 363-365
65. Deshpande K.S., Hatem C., Ulrich H.L., et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 33 1 (2005) 13-20 [discussion: 234-5]
66. Sznajder J.I., Zveibil F.R., Bitterman H., et al. Central vein catheterization. Failure and complication rates by three percutaneous approaches. Arch Intern Med 146 2 (1986) 259-261
67. Bernard R.W., Stahl W.M., and Chase Jr. R.M. Subclavian vein catheterizations: a prospective study. II. Infectious complications. Ann Surg 173 2 (1971) 191-200
68. Maki D.G., Ringer M., and Alvarado C.J. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338 8763 (1991) 339-343
69. Mimoz O., Villeminey S., Ragot S., et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med 167 19 (2007) 2066-2072
70. Humar A., Ostromecki A., Direnfeld J., et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 31 4 (2000) 1001-1007
71. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136 11 (2002) 792-801
72. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 37 6 (2003) 764-771
73. Parienti J.J., du Cheyron D., Ramakers M., et al. Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study. Crit Care Med 32 3 (2004) 708-713
74. Salzman M.B., Isenberg H.D., and Rubin L.G. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 31 3 (1993) 475-479
75. Niel-Weise B.S., Daha T.J., and van den Broek P.J. Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials. J Hosp Infect 62 4 (2006) 406-413
76. Bouza E., Munoz P., Lopez-Rodriguez J., et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect 54 4 (2003) 279-287
77. Casey A.L., Burnell S., Whinn H., et al. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect 65 3 (2007) 212-218
78. Yebenes J.C., Vidaur L., Serra-Prat M., et al. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control 32 5 (2004) 291-295
79. Adams K.S., Zehrer C.L., and Thomas W. Comparison of a needleless system with conventional heparin locks. Am J Infect Control 21 5 (1993) 263-269
80. Maragakis L.L., Bradley K.L., Song X., et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 27 1 (2006) 67-70
81. Field K., McFarlane C., Cheng A.C., et al. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol 28 5 (2007) 610-613
82. Rupp M.E., Sholtz L.A., Jourdan D.R., et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis 44 11 (2007) 1408-1414
83. Falagas M.E., Fragoulis K., Bliziotis I.A., et al. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 59 3 (2007) 359-369
84. Borschel D.M., Chenoweth C.E., Kaufman S.R., et al. Are antiseptic-coated central venous catheters effective in a real-world setting?. Am J Infect Control 34 6 (2006) 388-393
85. McConnell S.A., Gubbins P.O., and Anaissie E.J. Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash. Clin Infect Dis 39 12 (2004) 1829-1833
86. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281 3 (1999) 261-267
87. Kamal G.D., Pfaller M.A., Rempe L.E., et al. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265 18 (1991) 2364-2368
88. Walder B., Pittet D., and Tramer M.R. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 23 12 (2002) 748-756
89. Geffers C., Zuschneid I., Eckmanns T., et al. The relationship between methodological trial quality and the effects of impregnated central venous catheters. Intensive Care Med 29 3 (2003) 403-409
90. Brun-Buisson C., Doyon F., Sollet J.P., et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 30 5 (2004) 837-843
91. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143 8 (2005) 570-580
92. Bong J.J., Kite P., Wilco M.H., et al. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J Clin Pathol 56 10 (2003) 731-735
93. Ranucci M., Isgro G., Giomarelli P.P., et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31 1 (2003) 52-59
94. Leape L.L. Error in medicine. JAMA 272 23 (1994) 1851-1857
95. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32 10 (2004) 2014-2020
96. Reason J. Human error. 1st edition (1990), Cambridge University Press, New York, NY
97. Pronovost P., Berenholtz S., Dorman T., et al. Improving communication in the ICU using daily goals. J Crit Care 18 2 (2003) 71-75
98. Berenholtz S.M., Milanovich S., Faircloth A., et al. Improving care for the ventilated patient. Jt Comm J Qual Saf 30 4 (2004) 195-204
99. Sherertz R.J. Surveillance for infections associated with vascular catheters. Infect Control Hosp Epidemiol 17 11 (1996) 746-752
100. Eggimann P., Harbarth S., Constantin M.N., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 9218 (2000) 1864-1868
101. Warren D.K., Zack J.E., Cox M.J., et al. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 31 7 (2003) 1959-1963
102. Misset B., Timsit J.F., Dumay M.F., et al. A continuous quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med 30 3 (2004) 395-400
103. Wall R.J., Ely E.W., Elasy T.A., et al. Using real time process measurements to reduce catheter related bloodstream infections in the intensive care unit. Qual Saf Health Care 14 4 (2005) 295-302
104. Young E.M., Commiskey M.L., and Wilson S.J. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention. Am J Infect Control 34 8 (2006) 503-506
105. Hatler C.W., Mast D., Corderella J., et al. Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. Am J Crit Care 15 6 (2006) 549-555
106. Render M.L., Brungs S., Kotagal U., et al. Evidence-based practice to reduce central line infections. Jt Comm J Qual Patient Saf 32 5 (2006) 253-260
107. Warren D.K., Cosgrove S.E., Diekema D.J., et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 27 7 (2006) 662-669
108. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 26 (2006) 2725-2732
109. Ho K.M., and Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 58 2 (2006) 281-287
110. Turcotte S., Dube S., and Beauchamp G. Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg 30 8 (2006) 1605-1619
111. Krein S.L., Hofer T.P., Kowalski C.P., et al. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc 82 6 (2007) 672-678
112. Rubinson L., Haponik E.F., Wu A.W., et al. Internists' adherence to guidelines for prevention of intravascular catheter infections. JAMA 290 21 (2003) 2802
113. Pronovost P., and Sexton B. Assessing safety culture: guidelines and recommendations. Qual Saf Health Care 14 4 (2005) 231-233
114. Kidd K.M., Sinkowitz-Cochran R.L., Giblin T.B., et al. Barriers to and facilitators of implementing an intervention to reduce the incidence of catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 28 1 (2007) 103-105
115. Halton K., and Graves N. Economic evaluation and catheter-related bloodstream infections. Emerg Infect Dis 13 6 (2007) 815-823
116. Pronovost P.J., Berenholtz S.M., Goeschel C.A., et al. Creating high reliability in health care organizations. Health Serv Res 41 4 Pt 2 (2006) 1599-1617
117. Pronovost P., Holzmueller C.G., Needham D.M., et al. How will we know patients are safer? An organization-wide approach to measuring and improving safety. Crit Care Med 34 7 (2006) 1988-1995
118. Medicare Program: changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Office of the Federal Register 72 (2007) 47379-47428